Cardiovascular risk factors Clinical Trials
Conditions / Cardiovascular risk factors
Delta Trials tracks 79 clinical trials for Cardiovascular risk factors in its publicly accessible dataset. Among the listed trials, 12 open for participant enrollment and 50 trials have reached completion. This research is carried out at 897 clinical sites around the world. An additional 17 trials have active registrations outside the recruiting and completed categories. Since 2020, 1 trial have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
79
Total Trials
12
Recruiting
50
Completed
17
Other Active
1
Terminated since 2020
897
Study Locations
Browse by location (897 total)
- Madrid, Spain 6 trialsAll trials in Madrid, Spain
- Philadelphia, United States 4 trialsAll trials in Philadelphia, United States
- Athens, Greece 3 trialsAll trials in Athens, Greece
- Athens, Greece 3 trialsAll trials in Athens, Greece
- Edinburgh, United Kingdom 3 trialsAll trials in Edinburgh, United Kingdom
- Toronto, Canada 3 trialsAll trials in Toronto, Canada
- Paris, France 2 trialsAll trials in Paris, France
- Gland, Switzerland 2 trialsAll trials in Gland, Switzerland
- Ilanz, Switzerland 2 trialsAll trials in Ilanz, Switzerland
- Paris, France 2 trialsAll trials in Paris, France
- Zürich, Switzerland 2 trialsAll trials in Zürich, Switzerland
- Leuven, Belgium 2 trialsAll trials in Leuven, Belgium
- Thun, Switzerland 2 trialsAll trials in Thun, Switzerland
- Lugano, Switzerland 2 trialsAll trials in Lugano, Switzerland
- Aix-en-Provence, France 2 trialsAll trials in Aix-en-Provence, France
- Oxford, United Kingdom 2 trialsAll trials in Oxford, United Kingdom
- Seoul, South Korea 2 trialsAll trials in Seoul, South Korea
- Locarno, Switzerland 2 trialsAll trials in Locarno, Switzerland
- Birmingham, United Kingdom 2 trialsAll trials in Birmingham, United Kingdom
- London, United Kingdom 2 trialsAll trials in London, United Kingdom